Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter]

被引：0
|
作者：
Björn Zethelius
Soffia Gudbjörnsdottir
Björn Eliasson
Katarina Eeg-Olofsson
Ann-Marie Svensson
Jan Cederholm
机构：
[1] Uppsala University,Department of Public Health and Caring Sciences/Geriatrics, Uppsala Science Park
[2] Medical Products Agency,Department of Medicine, Sahlgrenska University Hospital
[3] University of Gothenburg,Department of Public Health and Caring Sciences/Family Medicine
[4] Uppsala University,undefined
来源：
Diabetologia | 2016年 / 59卷
关键词：
Albuminuria; Atrial fibrillation; Epidemiology; Longitudinal study design; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 864
页数：1
相关论文
共 39 条
  • [21] Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations. Reply to Christensen D, Hjort L, Mpagama S et al [letter]
    Goedecke, Julia H. H.
    Pheiffer, Carmen
    Mendham, Amy E. E.
    DIABETOLOGIA, 2023, 66 (04) : 780 - 782
  • [22] Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations. Reply to Christensen D, Hjort L, Mpagama S et al [letter]
    Julia H. Goedecke
    Carmen Pheiffer
    Amy E. Mendham
    Diabetologia, 2023, 66 : 780 - 782
  • [23] Reply to Letter by Akboga et al Entitled "Are Endocan and Ischemia-Modified Albumin Reliable Biomarkers for Endothelial Dysfunction in Type 2 Diabetes Mellitus?"
    Balamir, Ilhan
    Ates, Ihsan
    Topcuoglu, Canan
    Turhan, Turan
    ANGIOLOGY, 2020, 71 (05) : 481 - 481
  • [24] ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter]
    D. R. Matthews
    S. E. Inzucchi
    Diabetologia, 2012, 55 : 2856 - 2857
  • [25] ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter]
    Matthews, D. R.
    Inzucchi, S. E.
    DIABETOLOGIA, 2012, 55 (10) : 2856 - 2857
  • [26] Letter to the Editor from Watanabe et al: "Long-term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study"
    Watanabe, Hirotaka
    Takahara, Mitsuyoshi
    Katakami, Naoto
    Shimomura, Iichiro
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : e2376 - e2377
  • [27] Reply to Foster, T.P.; Schatz, D. Comment on "Lombardo et al. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children 2022, 9, 1087"
    Lombardo, Fortunato
    Bombaci, Bruno
    Alibrandi, Angela
    Visalli, Giulia
    Salzano, Giuseppina
    Passanisi, Stefano
    CHILDREN-BASEL, 2025, 12 (02):
  • [28] Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'
    Ghoshal, Samit
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1541 - 1541
  • [29] Letter by Chen et al Regarding Article, "Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial"
    Chen, Zhi-Qing
    Chen, Feng
    Li, Lang
    CIRCULATION, 2020, 142 (10) : E127 - E128
  • [30] Author Reply to Letter to the Editor: In Response to: Comment on Sutton et al.'s "Allopurinol and the Risk of Diabetic Macular Edema among US Veterans with Type 2 Diabetes"
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H. H.
    Hardin, James W. W.
    Ambati, Jayakrishna
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (07) : 1454 - 1456
1234